{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:12:23Z","timestamp":1772856743468,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.lfs.2004.11.013","type":"journal-article","created":{"date-parts":[[2005,2,10]],"date-time":"2005-02-10T23:35:31Z","timestamp":1108078531000},"page":"2445-2456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["In vivo demonstration of muscarinic receptor binding activity of N-desethyl-oxybutynin, active metabolite of oxybutynin"],"prefix":"10.1016","volume":"76","author":[{"given":"Tomomi","family":"Oki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lfs.2004.11.013_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0773.1984.tb01969.x","article-title":"Antimuscarinic activity of oxybutynin in the human plasma quantitated by a radioreceptor assay","volume":"55","author":"Aaltonen","year":"1984","journal-title":"Acta Pharmacologica et Toxicologica"},{"issue":"5","key":"10.1016\/j.lfs.2004.11.013_bib2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1472-8206.1999.tb00362.x","article-title":"Pharmacological characterization of muscarinic receptors implicated in rabbit detrusor muscle contraction and activation of inositol phospholipid hydrolysis in rabbit detrusor and parotid gland","volume":"13","author":"Barras","year":"1999","journal-title":"Fundamental and Clinical Pharmacology"},{"issue":"3","key":"10.1016\/j.lfs.2004.11.013_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0163-7258(93)90027-B","article-title":"Muscarinic receptor: characterization, coupling and function","volume":"58","author":"Caufield","year":"1993","journal-title":"Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/j.lfs.2004.11.013_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0022-5347(05)66095-8","article-title":"A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence","volume":"166","author":"Davila","year":"2001","journal-title":"Journal of Urology"},{"issue":"3","key":"10.1016\/j.lfs.2004.11.013_bib5","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0022-3565(25)23162-7","article-title":"Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain","volume":"255","author":"Ehlert","year":"1990","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"19","key":"10.1016\/j.lfs.2004.11.013_bib6","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/0024-3205(88)90398-0","article-title":"Characterization of muscarinic receptor subtypes in human tissues","volume":"43","author":"Giraldo","year":"1988","journal-title":"Life Sciences"},{"issue":"7","key":"10.1016\/j.lfs.2004.11.013_bib7","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3109\/00498259209053145","article-title":"Measurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteers","volume":"22","author":"Hughes","year":"1992","journal-title":"Xenobiotica"},{"issue":"10","key":"10.1016\/j.lfs.2004.11.013_bib8","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/bms.1200081009","article-title":"Metabolism of oxybutynin: establishment of desethyloxybutynin and oxybutynin N-oxide formation in rat liver preparation using deuterium substitution and gas chromatographic mass spectrometric analysis","volume":"8","author":"Lindeke","year":"1981","journal-title":"Biomedical Mass Spectrometry"},{"issue":"1","key":"10.1016\/j.lfs.2004.11.013_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"Journal of Biological Chemistry"},{"issue":"24","key":"10.1016\/j.lfs.2004.11.013_bib10","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/S0024-3205(98)00495-0","article-title":"Ex vivo occupancy by tamslosin of \u03b11-adrenoceptors in rat tissues in relation to the plasma concentration","volume":"63","author":"Ohkura","year":"1998","journal-title":"Life Sciences"},{"issue":"5","key":"10.1016\/j.lfs.2004.11.013_bib11","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/01.ju.0000138472.16876.8d","article-title":"Demonstration of bladder-selective muscarinic receptor binding by intravesical oxybutynin to treat overactive bladder","volume":"172","author":"Oki","year":"2004","journal-title":"Journal of Urology"},{"issue":"4","key":"10.1016\/j.lfs.2004.11.013_bib12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.0306-5251.2001.01463.x","article-title":"Effect of OROS\u00ae controlled-release delivery on the pharmacokinetics and pharmacodynamics of oxybutynin chloride","volume":"52","author":"Sathyan","year":"2001","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"14","key":"10.1016\/j.lfs.2004.11.013_bib13","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0024-3205(01)01247-4","article-title":"Effects of AH-9700, (+)-pentazocine, DTG and oxybutynin on micturition in anesthetized rats with acetone-induced cystitis","volume":"69","author":"Shimizu","year":"2001","journal-title":"Life Sciences"},{"issue":"2","key":"10.1016\/j.lfs.2004.11.013_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1254\/jphs.94.122","article-title":"Effects of 4-ethyamino-2-butynyl(2-cyclohexyl-2-phenyl)glycolate hydrochloride, a metabolite of oxybutynin, on bladder specimens and rhythmic bladder contraction in rats in comparison with oxybutynin","volume":"94","author":"Uchida","year":"2004","journal-title":"Journal of Pharmacological Sciences"},{"issue":"3","key":"10.1016\/j.lfs.2004.11.013_bib15","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0022-5347(01)65148-6","article-title":"Comparison of oxybutynin and its active metabolite, N-desethyl-oxybutynin, in the human detrusor and parotid gland","volume":"157","author":"Waldeck","year":"1997","journal-title":"Journal of Urology"},{"issue":"1","key":"10.1016\/j.lfs.2004.11.013_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/nau.2124","article-title":"Actions of the new antimuscarinic compound Lu 25-109 on isolated human and pig dertusor","volume":"21","author":"Waldeck","year":"2002","journal-title":"Neurourology and Urodynamics"},{"issue":"2","key":"10.1016\/j.lfs.2004.11.013_bib17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0022-3565(25)09628-4","article-title":"Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins","volume":"273","author":"Wang","year":"1995","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.lfs.2004.11.013_bib18","first-page":"67","article-title":"The metabolism of oxybutynin is dependent on CYP3A and not on CYP2D6","volume":"50","author":"Yaich","year":"1995","journal-title":"Therapie"},{"issue":"2","key":"10.1016\/j.lfs.2004.11.013_bib19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0026-895X(25)13496-2","article-title":"Brain nicotinic acetylcholine receptors. Biochemical characterization by neosurugatoxin","volume":"28","author":"Yamada","year":"1985","journal-title":"Molecular Pharmacology"},{"issue":"8","key":"10.1016\/j.lfs.2004.11.013_bib20","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/sj.bjp.0705371","article-title":"In vitro and ex vivo effects of a selective nociceptin\/orphanin FQ (N\/OFQ) peptide receptor antagonist, CompB, on specific binding of [3H]N\/OFQ and [35S]GTP\u03b3S in rat brain and spinal cord","volume":"139","author":"Yamada","year":"2003","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.lfs.2004.11.013_bib21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0022-3565(25)32274-3","article-title":"Characterization of alpha-1 adrenergic receptor in the heart using [3H]WB4101: effect of 6-hydroxydopamine treatment","volume":"215","author":"Yamada","year":"1980","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/j.lfs.2004.11.013_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00002512-199506030-00007","article-title":"Oxybutynin: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability","volume":"6","author":"Yarker","year":"1995","journal-title":"Drugs and Aging"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320505000457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320505000457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:05:54Z","timestamp":1758398754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320505000457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":22,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0024320505000457"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2004.11.013","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo demonstration of muscarinic receptor binding activity of N-desethyl-oxybutynin, active metabolite of oxybutynin","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2004.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}